Cargando…
The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario
BACKGROUND: Medium chain acyl-CoA dehydrogenase deficiency (MCADD) is a disorder of mitochondrial fatty acid oxidation and is one of the most common inborn errors of metabolism. Identification of MCADD via newborn screening permits the introduction of interventions that can significantly reduce asso...
Autores principales: | Kennedy, Shelley, Potter, Beth K, Wilson, Kumanan, Fisher, Lawrence, Geraghty, Michael, Milburn, Jennifer, Chakraborty, Pranesh |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996355/ https://www.ncbi.nlm.nih.gov/pubmed/21083904 http://dx.doi.org/10.1186/1471-2431-10-82 |
Ejemplares similares
-
A Young Female With Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCADD): A Case Report
por: Yusuf, Ibidapo Q, et al.
Publicado: (2023) -
Health services use among children diagnosed with medium-chain acyl-CoA dehydrogenase deficiency through newborn screening: a cohort study in Ontario, Canada
por: Karaceper, Maria D., et al.
Publicado: (2019) -
The health system impact of false positive newborn screening results for medium-chain acyl-CoA dehydrogenase deficiency: a cohort study
por: Karaceper, Maria D., et al.
Publicado: (2016) -
Protein misfolding is the molecular mechanism underlying MCADD identified in newborn screening
por: Maier, Esther M., et al.
Publicado: (2009) -
Cost-effectiveness analysis of universal newborn screening for medium chain acyl-CoA dehydrogenase deficiency in France
por: Hamers, Françoise F, et al.
Publicado: (2012)